• views: 169
• date: 15 May 2026
• posted by: 0nelove

Learn PBRER, DSUR, PADER, PSUR, signal detection, benefit-risk evaluation, QC, inspection readiness, and AI in PV
What you'll learn
Understand PSUR, PBRER, DSUR, PADER, and how aggregate safety reports fit into pharmacovigilance.
Identify key data sources used in aggregate reporting, including ICSRs, literature, exposure, and regulatory actions.
Review safety data for signals, benefit-risk questions, important risks, and emerging safety issues.
Build practical workflows for preparing, reviewing, and quality-checking aggregate safety reports.
Use AI responsibly to support summaries, literature review, trend checks, and report drafting without losing traceability.
Prepare for aggregate reporting roles, interviews, and real-world PV documentation tasks.
Requirements
Basic understanding of pharmacovigilance, drug safety, clinical research, or regulatory affairs is helpful but not required.
No prior aggregate reporting experience is required. The course explains key concepts step by step.
Interest in PSUR, PBRER, DSUR, PADER, signal detection, benefit-risk evaluation, or PV career development.
Description
This course contains the use of artificial intelligence.
Welcome to SafeMeds Academy.
This course is a practical, career-focused training program on pharmacovigilance aggregate reporting, covering PBRER, DSUR, PADER, PSUR, signal detection, benefit-risk evaluation, safety summaries, quality control, inspection readiness, and responsible AI-supported pharmacovigilance workflows.
The course is designed to help learners understand how aggregate safety reports are used in real pharmacovigilance and regulatory environments. You will learn how periodic reports connect cumulative safety data, medical interpretation, regulatory expectations, and defensible benefit-risk conclusions.
Throughout the course, you will explore key data sources used in aggregate reporting, including ICSRs, line listings, summary tabulations, literature, clinical trial data, post-marketing data, exposure data, regulatory actions, label changes, and safety commitments.
You will also learn how to review safety information for signals, emerging safety issues, important risks, and practical follow-up actions. The course includes workflows for preparing and reviewing aggregate reports, including PBRER structure, DSUR and PADER workflows, safety evaluation sections, QC checks, common reporting errors, inspection readiness, and finalization.
Because pharmacovigilance is evolving, the course also introduces the responsible use of AI in aggregate reporting. This includes AI-supported summaries, literature review, trend detection, prompting, traceability, hallucination risk, and human oversight.
By the end of the course, you will have a stronger practical understanding of aggregate reporting and how to approach PBRER, DSUR, PADER, PSUR, signals, benefit-risk evaluation, and safety documentation with more confidence.
Who this course is for
Pharmacovigilance, drug safety, clinical research, regulatory affairs, and medical writing learners who want practical aggregate reporting skills.
PV associates, case processors, safety specialists, students, and job seekers preparing for aggregate reporting or signal-related roles.
Professionals who want to understand PBRER, DSUR, PADER, PSUR, benefit-risk, safety summaries, and AI-supported PV workflows.



   
   
   

Forex Trading

Crypto Trading. 20 USD Bonus after KYC

We need your support!
Make a donation to help us stay online
        
Bitcoin (BTC)
bc1q08g9d22cxkawsjlf8etuek2pc9n2a3hs4cdrld
	
Bitcoin Cash (BCH)
qqvwexzhvgauxq2apgc4j0ewvcak6hh6lsnzmvtkem

Ethereum (ETH)
0xb55513D2c91A6e3c497621644ec99e206CDaf239

Litecoin (LTC)
ltc1qt6g2trfv9tjs4qj68sqc4uf0ukvc9jpnsyt59u

USDT (ERC20)
0xb55513D2c91A6e3c497621644ec99e206CDaf239

USDT (TRC20)
TYdPNrz7v1P9riWBWZ317oBgJueheGjATm

0 1 2 3 4 5

| Print version |

	Information
		Users of GUESTS are not allowed to comment this publication.